Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Shares Climb 8.8% – Should You Buy?

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF)’s stock price was up 8.8% on Wednesday. The company traded as high as $28.09 and last traded at $28.09. 294 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 3,061 shares. The stock had previously closed at $25.8150.

Analyst Ratings Changes

Several brokerages have issued reports on FSPKF. Citigroup upgraded shares of Fisher & Paykel Healthcare to a “buy” rating in a report on Thursday, September 10th. Royal Bank Of Canada upgraded shares of Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a research note on Tuesday, September 15th. Two investment analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, Fisher & Paykel Healthcare currently has an average rating of “Buy”.

Fisher & Paykel Healthcare Price Performance

The stock has a fifty day moving average price of $25.85 and a 200-day moving average price of $23.61.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products used in respiratory care, acute care and the treatment of obstructive sleep apnea. Its technologies are designed to support breathing, improve patient comfort and help healthcare professionals deliver respiratory therapies in hospitals, clinics and the home.

The company’s product portfolio includes respiratory humidification systems, heated breathing circuits, nasal high-flow therapy products, anesthesia and operating-room equipment, neonatal respiratory care products, and masks and related systems for sleep apnea treatment.